GTPL Hathway Limited — Others, 30-04-2025: Copy of Newspaper Publication

FDC Limited plans to discontinue the manufacture and marketing of FUNGOTEK CREAM 1% 10G (Terbinafine 1% Cream) after a six-month notice period. This decision means the product will eventually be unavailable, urging patients currently using it to seek alternatives from healthcare professionals. The move to streamline product offerings may impact patients reliant on this medication, underscoring the necessity of physician support during the transition to other treatments. This strategic shift is aligned with FDC's focus on optimizing its portfolio.